Which companies manufacture aquablation machines for the treatment of Benign Prostatic Hyperplasia (BPH)?

Aquablation Machine Manufacturer

PROCEPT BioRobotics, Inc. (based in Redwood City, California, USA) manufactures the AquaBeam System, which is the aquablation device used for treating benign prostatic hyperplasia. 1, 2, 3

Device Details

• The system is marketed as the AquaBeam System and has received U.S. Food and Drug Administration approval 4
• The technology combines high-velocity waterjet ablation with real-time ultrasound imaging and robotic assistance for targeted removal of prostate tissue 2
• PROCEPT BioRobotics is the sole manufacturer of aquablation technology for BPH treatment 1, 3

Clinical Context

The AquaBeam System has been studied in major clinical trials including:

• WATER trial (NCT02505919): Evaluated prostates 30-80 mL comparing Aquablation to TURP 3
• WATER II trial (NCT03123250): Evaluated larger prostates 80-150 mL in a single-arm study 1, 3, 4

The European Association of Urology guidelines offer aquablation as a weak recommendation for patients with moderate-to-severe LUTS and prostate volumes of 30-80 mL as an alternative to TURP, though they emphasize informing patients about bleeding risk and lack of long-term follow-up data 5